10-hydroxycamptothecin has been researched along with folic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Li, Q; Liu, C; Su, L; Sun, B; Wang, Y; Zhang, B; Zhao, D; Zhao, Q; Zhao, X; Zu, Y | 1 |
| An, F; Diao, X; Hao, X; Li, W; Liu, Z; Wang, C; Yang, Y; Zhang, X | 1 |
| Cao, J; Cui, S; Gu, Y; Qian, Z; Zhu, H | 1 |
| Chen, Y; Fan, Z; Hou, Z; Li, Y; Lin, J; Ma, J; Su, G; Xie, L; Zhang, H; Zhang, Y; Zhu, X | 1 |
| Ao, M; Cao, Y; Hao, L; Hu, Z; Huang, J; Li, A; Li, P; Liu, J; Liu, Y; Ran, H; Wang, Z; Xu, F; Xu, J; Yao, Y | 1 |
5 other study(ies) available for 10-hydroxycamptothecin and folic acid
| Article | Year |
|---|---|
Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Camptothecin; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Humans; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Particle Size; Serum Albumin; X-Ray Diffraction | 2011 |
Carrier-free, functionalized drug nanoparticles for targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Maleic Anhydrides; Nanoparticles; Neoplasms; Polyethylene Glycols | 2012 |
Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Nude; Micelles; Neoplasms; Rats | 2013 |
Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Drug Carriers; Drug Compounding; Drug Synergism; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hyaluronic Acid; MCF-7 Cells; Methotrexate; Mice; Mice, Nude; Nanoparticles; Phosphatidylethanolamines; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Topics: Animals; Camptothecin; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Delivery Systems; Fluorocarbons; Folic Acid; Humans; Magnetite Nanoparticles; Mice; Mice, Nude; Molecular Imaging; Nanostructures; Theranostic Nanomedicine; Tissue Distribution; Ultrasonic Waves | 2018 |